bullish

AFT Pharmaceuticals (AFT): Q4 Update

104 Views07 Apr 2026 18:16
Broker
AFT this morning released its Q4 update. AFT noted it has had successful engagement with the US FDA and the product 'continues attract unsolicited...
What is covered in the Full Insight:
  • Q4 Update Release Summary
  • FY26 EBIT Guidance Reiteration
  • FY27 Revenue Target and Projections
  • Iron Product Development and FDA Engagement
  • South Africa Market Expansion
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 2-minute read)
Discussions
(Paid Plans Only)
chart-bar
Price Chart(Sign Up to Access)
analytics-chart
  • AFT Pharmaceuticals (AFT): Q4 Update
    07 Apr 2026
x